Paul N. Lucas
Chairman at ECOSYNTHETIX INC.
Net worth: 136 260 $ as of 2024-03-30
Profile
Paul N.
Lucas is currently the Chairman at Luminex Molecular Diagnostics, Inc., Vice Chairman at Pharmaceutical Manufacturers Association of Canada, Chairman at EcoSynthetix, Inc., Chairman at Induran Ventures, Inc., Director at Select Therapeutics, Inc., and Director at Rna Diagnostics, Inc. Previously, Mr. Lucas served as the President & Chief Executive Officer at GlaxoSmithKline, Inc. from 2000 to 2012.
He also held positions as Chairman at Tm Bioscience Corp., Innovative Medicines Canada, and Life Sciences Ontario.
Additionally, he was the Chairman at VIVO Cannabis, Inc. from 2017 to 2020.
Mr. Lucas has also served as a Director at Biochem Pharma, Inc., Canada's Research Based Pharmaceutical Cos., The Toronto Region Research Alliance, Allergen NCE, Inc., Ontario Genomics Institute, Montreal Invivo Organization, ABcann Medicinals, Inc., and Strategic Regional Research Alliance.
He was also a Principal at Eli Lilly Canada, Inc. and McNeil Pharmaceutical.
Mr. Lucas obtained his undergraduate degree from Queen's University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ECOSYNTHETIX INC.
0.06% | 2023-05-15 | 36,000 ( 0.06% ) | 136 260 $ | 2024-03-30 |
Paul N. Lucas active positions
| Companies | Position | Start |
|---|---|---|
| ECOSYNTHETIX INC. | Chairman | 2016-06-15 |
| Induran Ventures, Inc. | Chairman | - |
Luminex Molecular Diagnostics, Inc.
 Luminex Molecular Diagnostics, Inc. Medical/Nursing ServicesHealth Services Luminex Molecular Diagnostics, Inc. develops DNA based diagnostics tests and software solutions, which include genetic tests for disorders, drug metabolism and infectious diseases. The firm’s products include P450-2D6, P450-2C9, P450-2C19, AJ panel and CFTR. The company was founded in March 2007 and is headquartered in Toronto, Canada. | Chairman | - |
Rna Diagnostics, Inc.
 Rna Diagnostics, Inc. Medical SpecialtiesHealth Technology Rna Diagnostics, Inc. operates as a cancer diagnostics company which builds a platform of prognostic biomarker tools to help improve the lives of patients undergoing chemotherapy. The firm develops prognostic biomarker tools to improve the lives of women undergoing chemotherapy for breast cancer. It provides The RNA Disruption Assay (RDA), which provides physicians with an evaluation of how individual patients are responding to chemotherapy. The company was founded by Kenneth P. H. Pritzker in 2010 and is headquartered in Toronto, Canada. | Director/Board Member | - |
| Pharmaceutical Manufacturers Association of Canada | Director/Board Member | 2010-02-21 |
Select Therapeutics, Inc.
 Select Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Select Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is focused on the development of cell based therapeutics production. The company was founded by Clifford A. Lingwood in January 1997 and is headquartered in Brookline, MA. | Director/Board Member | 2010-02-21 |
Former positions of Paul N. Lucas
| Companies | Position | End |
|---|---|---|
| VIVO CANNABIS INC. | Chairman | 2020-12-30 |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Chief Executive Officer | 2012-05-31 |
| Canada's Research Based Pharmaceutical Cos. | Director/Board Member | - |
| ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░ | - |
| ░░░ ░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Paul N. Lucas
| Queen's University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ECOSYNTHETIX INC. | Process Industries |
| Private companies | 20 |
|---|---|
Select Therapeutics, Inc.
Select Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Select Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is focused on the development of cell based therapeutics production. The company was founded by Clifford A. Lingwood in January 1997 and is headquartered in Brookline, MA. | Health Technology |
Tm Bioscience Corp.
 Tm Bioscience Corp. BiotechnologyHealth Technology Tm Bioscience Corp. developed DNA-based diagnostics tests. It developed a suite of genetic tests that include tests for genetic disorders, drug metabolism and infectious diseases. Tm Bioscience was founded on December 19, 1980 and was headquartered in Toronto, Canada. | Health Technology |
Eli Lilly Canada, Inc.
 Eli Lilly Canada, Inc. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Eli Lilly Canada, Inc. is a healthcare leader that focuses on oncology, diabetes, autoimmunity, neurodegeneration, and pain. The private company is based in Scarborough, Canada. Established in 1938, the Canadian company collaborates with scientists to produce innovative medicines that make life better for people around the world. The company's mission is to discover and bring life-changing medicines to people who need them, improve the understanding and management of disease, and contribute to communities through philanthropy and volunteerism. | Health Technology |
Biochem Pharma, Inc.
 Biochem Pharma, Inc. Pharmaceuticals: OtherHealth Technology Biochem Pharma, Inc. provides bioinfomatics tools, biotechnology databases and consulting services to the genomics, proteomics and biopharmaceutical industries. They provide the cutting edge strategic intelligence needed to exploit information and to develop future business strategies. | Health Technology |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
Luminex Molecular Diagnostics, Inc.
Luminex Molecular Diagnostics, Inc. Medical/Nursing ServicesHealth Services Luminex Molecular Diagnostics, Inc. develops DNA based diagnostics tests and software solutions, which include genetic tests for disorders, drug metabolism and infectious diseases. The firm’s products include P450-2D6, P450-2C9, P450-2C19, AJ panel and CFTR. The company was founded in March 2007 and is headquartered in Toronto, Canada. | Health Services |
| McNeil Pharmaceutical | |
| Canada's Research Based Pharmaceutical Cos. | |
The Toronto Region Research Alliance
 The Toronto Region Research Alliance Miscellaneous Commercial ServicesCommercial Services The Toronto Region Research Alliance operated as a non-profit corporation. The company was headquartered in Toronto, Canada. | Commercial Services |
Allergen NCE, Inc.
 Allergen NCE, Inc. Miscellaneous Commercial ServicesCommercial Services Allergen NCE, Inc.is a national research network, seeking asthma and allergy treatment from a naturopath. It invests in training the next generation of researchers, innovators and clinician-scientists. The company was founded in 2004 and is headquartered in Hamilton, Canada. | Commercial Services |
| Pharmaceutical Manufacturers Association of Canada | |
Innovative Medicines Canada
 Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Innovative Medicines Canada manufactures medical and toilet products. The company was founded on April 23, 1914 and is headquartered in Ottawa, Canada. | Commercial Services |
| Ontario Genomics Institute | |
| Montreal Invivo Organization | |
| Life Sciences Ontario | |
Rna Diagnostics, Inc.
Rna Diagnostics, Inc. Medical SpecialtiesHealth Technology Rna Diagnostics, Inc. operates as a cancer diagnostics company which builds a platform of prognostic biomarker tools to help improve the lives of patients undergoing chemotherapy. The firm develops prognostic biomarker tools to improve the lives of women undergoing chemotherapy for breast cancer. It provides The RNA Disruption Assay (RDA), which provides physicians with an evaluation of how individual patients are responding to chemotherapy. The company was founded by Kenneth P. H. Pritzker in 2010 and is headquartered in Toronto, Canada. | Health Technology |
ABcann Medicinals, Inc.
 ABcann Medicinals, Inc. Pharmaceuticals: MajorHealth Technology ABcann Medicinals, Inc. operates medical marijuana producer. It offers chemical free grown in soil pesticide free pharmaceutical graded products. The firm provides organic standardized medical cannabis. The company was founded by Ken Clement and is headquartered in Napanee, Canada. | Health Technology |
| Induran Ventures, Inc. | |
VIVO Cannabis, Inc.
 VIVO Cannabis, Inc. Agricultural Commodities/MillingProcess Industries VIVO Cannabis, Inc. is a capital pool company, which engages in the production, sales, and research licenses from Health Canada; and operates indoor cultivation facilities. It operates through the following segments: Craft Cannabis Product, Medical Cannabis Clinic, and Corporate and International. The Craft Cannabis Product segment focuses on producing and selling cannabis and cannabis-derived products for direct sale to medical patient and for the adult-use market. The Medical Cannabis Clinic segment is involved and operated by its indirect wholly-owned subsidiary, Harvest Medicine Inc. The Corporate segment includes non-production related corporate activities and international operations. The company was founded by Ken Clement on April 12, 2007 and is headquartered in Toronto, Canada. | Process Industries |
| Strategic Regional Research Alliance |
- Stock Market
- Insiders
- Paul N. Lucas
